Having trouble accessing articles? Reset your cache.

Ark gains on restructuring

Ark Therapeutics Group plc (LSE:AKT) gained 1.47p (32%) to 6p on Thursday after announcing a restructuring and headcount reduction. Ark will now focus

Read the full 235 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE